HealthTech180
  • Home
  • Activities
  • Our Team
  • Contact Us
Select Page

Azeria Therapeutics Announces £32.0 Million Series B Financing

by admin | Nov 25, 2019 | Funding

 Azeria Therapeutics, a newly formed pioneer factor drug discovery company, announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund. Azeria was originally founded in 2017 by Sixth Element...

LUNAC Therapeutics Secures Over €3M to Develop Novel Anticoagulants

by admin | Nov 18, 2019 | Funding

LUNAC Therapeutics has spun out of the University of Leeds with €3.09M of funding from the university and the VC firm Epidarex Capital for the development of anticoagulants with a lower risk for bleeding than those currently available. The new anticoagulants will...

Hallura, an aesthetic medical company developing a new generation of Hyaluronic Acid Dermal Fillers, Closes Its $7M Financing Round

by admin | Nov 18, 2019 | Funding

Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round of $7M. The financing round was led by a group of US, Europe and Israel-based private investors; most of the investment...

Digital pathology startup PathAI closes $75M Series B round with investments from BMS & Merck

by admin | Nov 11, 2019 | Funding

Two of the largest drugmakers in the country are investing in a startup applying artificial intelligence in pathology. Boston-based PathAI said that it had closed its $75 million Series B financing round with funding from New York-based Bristol-Myers Squibb and the...

PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing

by admin | Nov 4, 2019 | Funding

The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs. A startup that aims to provide a software-as-a-service platform to allow genomic...
« Older Entries
Follow Us
We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.

Categories

Follow Us

Tags

AI Alzheimer antibodies Azitra Bioeq Biosimilar Cancer cardiovascular cell therapy CE Mark clinical trial Diagnostics Digital Health Distribution Drug Discovery Enterome EpiVax' FDA FDA approval funding fundraising HIV Immunogenicity Immunotherapies Licensing M&A medical device microbiome Neuro next-gen sequencing PathAI pathology Pepticom pharma RNA robots Shape Therapeutics skin software SurgiMab Therapeutics therapies USA VIrology Virus

Home
Activities
Our Team
Contact Us

 contact@healthtech180.com

Privacy Policy

© 2022 HealthTech180 Advisory S.L.